Henry Ford Cytoreductive Surgery and HIPEC Program - An Effective Option for Rare, Complex Cancers

Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) offers:

  • Regional therapy for rare or complex cancers that have spread to the lining of the abdomen, such as appendiceal, colorectal, gastric and certain gynecologic cancers.
  • An opportunity for improved survival and quality of life outcomes.
  • Potentially curative option, even for patients with significant tumor burden